225 related articles for article (PubMed ID: 7802694)
1. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
Tomiyama Y; Morii M; Takeguchi N
Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
[TBL] [Abstract][Full Text] [Related]
2. Restoration of acid secretion following treatment with proton pump inhibitors.
Shin JM; Sachs G
Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
[TBL] [Abstract][Full Text] [Related]
3. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
[TBL] [Abstract][Full Text] [Related]
5. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
[TBL] [Abstract][Full Text] [Related]
7. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
8. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
Besancon M; Simon A; Sachs G; Shin JM
J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
[TBL] [Abstract][Full Text] [Related]
9. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
10. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
[TBL] [Abstract][Full Text] [Related]
11. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
Lew EA; Barbuti RC; Kovacs TO; Sytnic B; Humphries TJ; Walsh JH
Aliment Pharmacol Ther; 1998 Jul; 12(7):667-72. PubMed ID: 9701531
[TBL] [Abstract][Full Text] [Related]
12. Oligomeric regulation of gastric H+,K+-ATPase.
Morii M; Hayata Y; Mizoguchi K; Takeguchi N
J Biol Chem; 1996 Feb; 271(8):4068-72. PubMed ID: 8626741
[TBL] [Abstract][Full Text] [Related]
13. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
Morii M; Takeguchi N
J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
[TBL] [Abstract][Full Text] [Related]
14. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
Morii M; Hamatani K; Takeguchi N
Biochem Pharmacol; 1995 Jun; 49(12):1729-34. PubMed ID: 7598734
[TBL] [Abstract][Full Text] [Related]
15. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
Nagaya H; Inatomi N; Nohara A; Satoh H
Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
[TBL] [Abstract][Full Text] [Related]
16. New fluorescent probes E3810 and methoxy E3810 for determining distributions of the apical membrane and the acidic compartment of gastric acid secreting cells.
Takeguchi N; Yamanouchi T; Sakai H; Morii M
Jpn J Physiol; 1992; 42(1):75-88. PubMed ID: 1320706
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
Lorentzon P; Bayati A; Lee H; Andersson K
Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
[No Abstract] [Full Text] [Related]
18. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
19. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
Nagaya H; Satoh H
Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
[TBL] [Abstract][Full Text] [Related]
20. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
Hirai M; Azuma T; Ito S; Kato T; Kohli Y
J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
